Head-to-head exploratory cohort of a Phase 3 trial showed first-in-class poze-cemdi combination treatment helped patients achieve and maintain greater disease...
New data demonstrate the actionability of clonoSEQ for tailoring treatment decisions in patients with MCL, CLL, MM and ALL Studies...
NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical...
BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing...
Decision follows observations of liver transaminitis without clinically significant symptoms in some subjects on azelaprag Company will evaluate data from...
TEMPE, Ariz., Dec. 6, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in November for the 15th consecutive...
MIAMI, Dec. 6, 2024 /PRNewswire/ -- eMerge Americas, the premier global technology conference and expo shaping the future of tech, is...
The study is one of five clinical efforts - three IIT proof-of-concept studies and two Phase 2 studies - of...
Live webcast on Thursday, December 12th at 4:00 PM ET LA JOLLA, CA, Dec. 06, 2024 (GLOBE NEWSWIRE) -- GRI...
ISS Notes Need for Significant Board Change at AIM Due to Clinical Failure and Lack of Transparency According to ISS...
Breakthrough in Delivering Chimeric Bait Receptors to Immune Cells Accelerates Development LONDON, UK / ACCESSWIRE / December 6, 2024 /...
OSAKA, Japan and MONTREAL , Dec. 5, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that...
Burlington, Ontario--(Newsfile Corp. - December 5, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian...
Total Revenues of $699.2M, up 13% Year Over YearSubscription Services Revenues of $580.9M, up 17% Year Over Year PLEASANTON, Calif.,...
NEW YORK, Dec. 5, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global eclinical solutions...
NAPLES, FL / ACCESSWIRE / December 5, 2024 / Stemtech Corporation (OTCQB:STEK), a US-based company announced this past Tuesday its...
RAHWAY, NJ / ACCESSWIRE / December 5, 2024 / Merck (NYSE:MRK), known as MSD outside of the United States and...
NEW YORK, Dec. 5, 2024 /PRNewswire/ -- MM+M has announced its sixth class of 40 Under 40 honorees. The program...
Canalevia®-CA1 is a canine-specific formulation of crofelemer, Jaguar's novel, oral plant-based drug sustainably harvested from the Croton lechleri treeCrofelemer, the...
Live webcast discussion featuring internationally renowned Glioblastoma Multiforme (GBM) Key Opinion LeadersCompany committed to addressing the most aggressive type of...